Anti-Human CD85j (ILT2) SAFIRE Purified
Additional HP-F1 Formats
Cat.No. | Format | Starting From |
---|---|---|
62111-25 | SAFIRE Purified | $ 255.00 |
description
Additional Information
Clone:
|
HP-F1
|
Format:
|
SAFIRE Purified
|
Applications:
|
FC, FA
|
Reactivity:
|
Human
|
Isotype:
|
Mouse IgG1, kappa
|
Research Interest: | Adaptive Immunity, Innate Immunity |
---|---|
Cell Type: | T Cells, Macrophage / Monocyte, Dendritic Cells, NK and NKT Cells |
Application: | FC, FA |
Clone: | HP-F1 |
Preparation:
|
The product should be stored undiluted at 4°C. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography.
|
Formulation:
|
Phosphate-buffered aqueous solution, ph7.2.
|
References:
|
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., ... & López-Botet, M. (1997). A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. The Journal of experimental medicine, 186(11), 1809-1818. Bellón, T., Kitzig, F., Sayós, J., & López-Botet, M. (2002). Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. The Journal of Immunology, 168(7), 3351-3359. Tenca, C., Merlo, A., Merck, E., Bates, E. E., Saverino, D., Simone, R., ... & Ciccone, E. (2005). CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. The Journal of Immunology, 174(11), 6757-6763. |